464 related articles for article (PubMed ID: 28069884)
1. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.
Xu HT; Hassounah SA; Colby-Germinario SP; Oliveira M; Fogarty C; Quan Y; Han Y; Golubkov O; Ibanescu I; Brenner B; Stranix BR; Wainberg MA
J Antimicrob Chemother; 2017 Mar; 72(3):727-734. PubMed ID: 28069884
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Ribonucleotide 5'-Triphosphate Analogs as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase by Using Nonradioactive Polymerase Assays.
Lu G; Bluemling GR; Collop P; Hager M; Kuiper D; Gurale BP; Painter GR; De La Rosa A; Kolykhalov AA
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993851
[TBL] [Abstract][Full Text] [Related]
4. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of Zika virus NS5 RNA-dependent RNA polymerase inhibitors.
Lin Y; Zhang H; Song W; Si S; Han Y; Jiang J
Int J Antimicrob Agents; 2019 Oct; 54(4):502-506. PubMed ID: 31310806
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures.
Elfiky AA; Ismail AM
SAR QSAR Environ Res; 2018 May; 29(5):409-418. PubMed ID: 29652194
[TBL] [Abstract][Full Text] [Related]
8. Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2'-modified nucleotide analogues.
Potisopon S; Ferron F; Fattorini V; Selisko B; Canard B
Antiviral Res; 2017 Apr; 140():25-36. PubMed ID: 28041959
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase.
Godoy AS; Lima GM; Oliveira KI; Torres NU; Maluf FV; Guido RV; Oliva G
Nat Commun; 2017 Mar; 8():14764. PubMed ID: 28345596
[TBL] [Abstract][Full Text] [Related]
10. Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase.
Hercík K; Kozak J; Šála M; Dejmek M; Hřebabecký H; Zborníková E; Smola M; Ruzek D; Nencka R; Boura E
Antiviral Res; 2017 Jan; 137():131-133. PubMed ID: 27902932
[TBL] [Abstract][Full Text] [Related]
11. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
[TBL] [Abstract][Full Text] [Related]
12. Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro.
Boccuto A; Dragoni F; Picarazzi F; Lai A; Della Ventura C; Veo C; Giammarino F; Saladini F; Zehender G; Zazzi M; Mori M; Vicenti I
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800884
[TBL] [Abstract][Full Text] [Related]
13. Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials.
Elfiky AA
J Med Virol; 2016 Dec; 88(12):2044-2051. PubMed ID: 27604059
[TBL] [Abstract][Full Text] [Related]
14. Cell-line dependent antiviral activity of sofosbuvir against Zika virus.
Mumtaz N; Jimmerson LC; Bushman LR; Kiser JJ; Aron G; Reusken CBEM; Koopmans MPG; van Kampen JJA
Antiviral Res; 2017 Oct; 146():161-163. PubMed ID: 28912011
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
[TBL] [Abstract][Full Text] [Related]
16. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking.
Tarannum H; Nandi S
Comb Chem High Throughput Screen; 2022; 25(4):702-719. PubMed ID: 33475069
[TBL] [Abstract][Full Text] [Related]
17. The structure of Zika virus NS5 reveals a conserved domain conformation.
Wang B; Tan XF; Thurmond S; Zhang ZM; Lin A; Hai R; Song J
Nat Commun; 2017 Mar; 8():14763. PubMed ID: 28345600
[TBL] [Abstract][Full Text] [Related]
18. The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication.
Sacramento CQ; de Melo GR; de Freitas CS; Rocha N; Hoelz LV; Miranda M; Fintelman-Rodrigues N; Marttorelli A; Ferreira AC; Barbosa-Lima G; Abrantes JL; Vieira YR; Bastos MM; de Mello Volotão E; Nunes EP; Tschoeke DA; Leomil L; Loiola EC; Trindade P; Rehen SK; Bozza FA; Bozza PT; Boechat N; Thompson FL; de Filippis AM; Brüning K; Souza TM
Sci Rep; 2017 Jan; 7():40920. PubMed ID: 28098253
[TBL] [Abstract][Full Text] [Related]
19. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.
Mottin M; de Paula Sousa BK; de Moraes Roso Mesquita NC; de Oliveira KIZ; Noske GD; Sartori GR; de Oliveira Albuquerque A; Urbina F; Puhl AC; Moreira-Filho JT; Souza GE; Guido RVC; Muratov E; Neves BJ; Martins da Silva JH; Clark AE; Siqueira-Neto JL; Perryman AL; Oliva G; Ekins S; Andrade CH
J Chem Inf Model; 2022 Dec; 62(24):6825-6843. PubMed ID: 36239304
[TBL] [Abstract][Full Text] [Related]
20. Novel guanosine derivatives against Zika virus polymerase in silico.
Elfiky AA
J Med Virol; 2020 Jan; 92(1):11-16. PubMed ID: 31436327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
